Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sarasin & Partners is a prominent London-based asset management firm that manages over £18 billion for charities, institutions, and private individuals. The firm is recognized for its thematic investment approach, which identifies long-term global trends, including significant exposure to the healthcare and life sciences sectors through its global equity and thematic funds. While not a drug developer itself, Sarasin & Partners actively invests in innovative pharmaceutical and medical technology companies that align with their 'Health Care Tomorrow' and 'Digitalization' themes. The firm is also a leader in ESG (Environmental, Social, and Governance) integration, ensuring that their portfolio companies meet high standards of corporate responsibility. Sarasin & Partners operates as a partnership, with the J. Safra Sarasin Group as a strategic partner and majority owner.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sarasin & Partners.